Cancer‐associated kinase domain variants in the epidermal growth factor receptor (EGFR) are common in non‐small‐cell lung cancer (NSCLC) as they can result in the increased ligand‐independent kinase activity of the receptor. The gene discussed is EGFR; the disease is cancer.